Results 141 to 150 of about 5,707,439 (181)
The mechanism of tigecycline resistance in A. baumannii remains largely unclear. In this study, we selected a tigecycline-resistant and a tigecycline-susceptible strain from a tigecycline-susceptible and a resistant strain, respectively.
Di Xiao, Qinghua Zou
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The emergence of clinical resistance to tigecycline
International Journal of Antimicrobial Agents, 2013Tigecycline (TIG) exhibits broad-spectrum activity against many Gram-positive and Gram-negative pathogens. However, clinical resistance has emerged recently and has been detected following treatment with TIG. This observation suggests that long-term monotherapy may carry a high risk for TIG resistance.
Yun Cai, Rui Wang, Xu Liu
exaly +3 more sources
RshA mutations contributing to tigecycline resistance in Mycobacteroides abscessus
Journal of Medical Microbiology, 2022Tigecycline is an important rescue antibiotic for many bacterial infections. In Mycobacteroides abscessus , tigecycline resistance has been associated with dysregulated stress response caused by aberrations in the interaction of the SigH and RshA factors.
Kar Men Aw +4 more
openaire +3 more sources
The emergence of TMexCD1-TOprJ1, a novel transferable resistance-nodulation-division (RND)-type efflux pump conferring resistance to tigecycline, is now a serious public health issue in the world.
Jinhu Huang +2 more
exaly +2 more sources
Mechanisms of tigecycline resistance in Gram-negative bacteria: A narrative review
Tigecycline serves as a critical "final-resort" antibiotic for treating bacterial infections caused by multidrug-resistant bacteria for which treatment options are severely limited.
Hai Xu, Xiuhua Pang, Chengzhang Fu
exaly +2 more sources
Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review [PDF]
Tigecycline is unique glycylcycline class of semisynthetic antimicrobial agents developed for the treatment of polymicrobial infections caused by multidrug-resistant Gram-positive and Gram-negative pathogens.
Farajolah Maleki +2 more
exaly +2 more sources
Phytomedicine
BACKGROUND Tigecycline is one of the few effective treatments for multidrug-resistant bacteria. However, the recent emergence and spread of high-level tigecycline resistance in Enterobacteriaceae have significantly limited its clinical use.
Yajun Zhai
exaly +2 more sources
BACKGROUND Tigecycline is one of the few effective treatments for multidrug-resistant bacteria. However, the recent emergence and spread of high-level tigecycline resistance in Enterobacteriaceae have significantly limited its clinical use.
Yajun Zhai
exaly +2 more sources
Clinical Microbiology and Infection, 2023
OBJECTIVE To investigate the prevalence of a tet(A) gene variant and its role in developing high-level tigecycline resistance among carbapenem-resistant Klebsiella pneumoniae (CRKP) clinical isolates.
Runhao Yu +8 more
semanticscholar +1 more source
OBJECTIVE To investigate the prevalence of a tet(A) gene variant and its role in developing high-level tigecycline resistance among carbapenem-resistant Klebsiella pneumoniae (CRKP) clinical isolates.
Runhao Yu +8 more
semanticscholar +1 more source
Journal of Hazardous Materials, 2023
Livestock-derived tetX-positive Escherichia coli with tigecycline resistance poses a serious risk to public health. Fitness costs, antibiotic residues, and other tetracycline resistance genes (TRGs) are fundamental in determining the spread of tetX in ...
Tao Chen +12 more
semanticscholar +1 more source
Livestock-derived tetX-positive Escherichia coli with tigecycline resistance poses a serious risk to public health. Fitness costs, antibiotic residues, and other tetracycline resistance genes (TRGs) are fundamental in determining the spread of tetX in ...
Tao Chen +12 more
semanticscholar +1 more source
International Journal of Antimicrobial Agents, 2023
The emergence of pathogens resistant to both tigecycline and carbapenem poses a threat to public health globally. Continuous emergence of novel tet(X) variants accelerates the tigecycline resistance crisis.
Xiaoyu Lu +6 more
semanticscholar +1 more source
The emergence of pathogens resistant to both tigecycline and carbapenem poses a threat to public health globally. Continuous emergence of novel tet(X) variants accelerates the tigecycline resistance crisis.
Xiaoyu Lu +6 more
semanticscholar +1 more source

